Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Medical Conditions
![Weight-Loss Drug Wegovy Cuts Heart Risk in New Study](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Weight-Loss-Drug-Wegovy-Cuts-Heart-Risk-in-New-Study-400x400.jpeg)
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
- By nasdaqpicks.com
- . 8 August 2023
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
![Learning a Language May Stave Off Dementia, but Are Apps the Way to Go?](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Learning-a-Language-May-Stave-Off-Dementia-but-Are-Apps-400x400.jpeg)
Learning a Language May Stave Off Dementia, but Are Apps the Way to Go?
- By nasdaqpicks.com
- . 6 August 2023
Language-learning software is seen to strengthen cognition and combat loneliness in older adults. Source link
![Pfizer’s Covid Boost Crashes to Earth](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Pfizers-Covid-Boost-Crashes-to-Earth-400x400.jpeg)
Pfizer’s Covid Boost Crashes to Earth
- By nasdaqpicks.com
- . 6 August 2023
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
![First Pill for Postpartum Depression Is Approved by FDA](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/First-Pill-for-Postpartum-Depression-Is-Approved-by-FDA-400x400.jpeg)
First Pill for Postpartum Depression Is Approved by FDA
- By nasdaqpicks.com
- . 5 August 2023
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link
![‘How Do I Do That?’ The New Hires of 2023 Are Unprepared for Work](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/‘How-Do-I-Do-That-The-New-Hires-of-2023-400x400.jpeg)
‘How Do I Do That?’ The New Hires of 2023 Are Unprepared for Work
- By nasdaqpicks.com
- . 2 August 2023
Listen to article (2 minutes) Roman Devengenzo was consulting for a robotics company in Silicon Valley last fall when he asked a newly minted mechanical
![It Might Be Quitting Time for the Fed's Rate Hawks](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/It-Might-Be-Quitting-Time-for-the-Fed039s-Rate-Hawks-400x400.jpeg)
It Might Be Quitting Time for the Fed's Rate Hawks
- By nasdaqpicks.com
- . 2 August 2023
Workers in some sectors are still leaving jobs at a higher rate than before the pandemic in a sign that the job-market realignment continues. Source
![Family of Henrietta Lacks, Whose Unique Cells Changed Science, Settles With Thermo Fisher](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Family-of-Henrietta-Lacks-Whose-Unique-Cells-Changed-Science-Settles-400x400.jpeg)
Family of Henrietta Lacks, Whose Unique Cells Changed Science, Settles With Thermo Fisher
- By nasdaqpicks.com
- . 1 August 2023
What to Read Next Source link
![Yellow's Shutdown Could Cost Taxpayers Money](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Yellow039s-Shutdown-Could-Cost-Taxpayers-Money-400x400.jpeg)
Yellow's Shutdown Could Cost Taxpayers Money
- By nasdaqpicks.com
- . 1 August 2023
Whether the federal government recovers the money it lent Yellow at the height of the pandemic would likely depend on how much Yellow raises by
![Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Venture-Capitalist-Seeks-to-Spur-Drug-Development-for-Rare-Autoimmune-400x400.jpeg)
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
- By nasdaqpicks.com
- . 1 August 2023
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
![Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Pfizer-Misses-Revenue-Expectations-Bets-on-Drug-Launches-to-Ease-400x400.jpeg)
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
- By nasdaqpicks.com
- . 1 August 2023
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link